© 2022 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
Frank J. Palella, MD
Articles
Key Takeaways for the Management of HIV PrEP
March 01, 2022
Video
A panel of experts share closing thoughts and advice for the management and uptake of HIV PrEP therapy.
Overcoming HIV PrEP Access Barriers With Advocacy Groups
March 01, 2022
Video
Carl Schmid shares insight on the use of advocacy groups to help patients overcome barriers to access for HIV PrEP therapy.
Improving Access and Uptake of HIV PrEP
February 22, 2022
Video
Sean E. Bland, JD; Frank J. Palella, MD; and Carl Schmid explore organizational opportunities to improve access to HIV PrEP therapy and population health management strategies to improve PrEP uptake.
COVID-19’s Effect on Access to HIV PrEP Therapy
February 22, 2022
Video
Carl Schmid discusses how the COVID-19 pandemic has amplified health care disparities and accessing HIV PrEP, and Frank J. Palella, MD, comments on the role of telehealth in improving access to PrEP.
Using Real-World Evidence for HIV PrEP Policies
February 15, 2022
Video
Ryan Bitton, PharmD, MBA, provides a payer perspective on the importance of creating future health policies for HIV PrEP agents using real-world evidence and considering the total cost of care for patients.
Unmet Needs for USPSTF Guidelines for HIV PrEP
February 15, 2022
Video
Ryan Bitton, PharmD, MBA; Sean E. Bland, JD; Frank J. Palella, MD; and Carl Schmid comment on challenges in the implementation of USPSTF guidelines for HIV PrEP as well as existing unknowns with the guidance.
USPSTF Guidelines: Approaching Optimal Therapy for HIV PrEP
February 08, 2022
Video
Frank J. Palella, MD, shares a provider perspective for steps to take in accordance with USPSTF guidelines for HIV PrEP to get patients appropriate medications, and Ryan Bitton, PharmD, MBA, shares a provider prospective on supporting expedited prior authorizations.
USPSTF Guidelines for HIV PrEP: Using Medical Management Techniques
February 08, 2022
Video
Sean E. Bland, JD, provides insight for when a health plan or issuer may use reasonable medical-management techniques, in accordance with USPSTF guidelines for HIV PrEP, and Ryan Bitton, PharmD, MBA, shares a payer perspective on utilization-management policies regarding PrEP.
USPSTF Guidelines for HIV PrEP: Coverage for Drugs vs Ancillary Services
February 01, 2022
Video
Carl Schmid and Frank J. Palella, MD, discuss how coverage differs for medications vs ancillary service costs for HIV PrEP based on USPSTF guidelines.
Understanding Implementation of USPSTF Guidelines for HIV PrEP
February 01, 2022
Video
Ryan Bitton, PharmD, MBA, and Frank J. Palella, MD, discuss facts about the implementation of USPSTF guidelines for HIV PrEP therapy.